Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $65.45 | Total: $327.25 |
| 1 | 10 | $55.44 | Total: $554.40 |
| 1 | 25 | $46.97 | Total: $1,174.25 |
| 1 | 50 | $40.04 | Total: $2,002.00 |
| 1 | 100 | $34.65 | Total: $3,465.00 |
Overview
Sitaxsentan (TBC-11251) is A selective endothelin A (ETA) receptor antagonist. Endothelin is an effective vasoconstrictor. Sitaxsentan blocks the binding of endothelin to its receptors, thereby eliminating the harmful effects of endothelin.
Chemical Properties
| Molecular Formula | C18H15ClN2O6S2 |
| Molecular Weight | 454.9 |
| CAS Numbers | 184036-34-8 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CC=1C=C2C(=CC1C)OCO2)(=O)C3=C(S(NC4=C(Cl)C(C)=NO4)(=O)=O)C=CS3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Marcus Chin, et al.Sitaxsentan-induced acute severe hepatitis treated with glucocorticoid therapy.Can Respir J. 2012 Jan-Feb;19[1] e1-2.